Viracta Therapeutics Inc (VIRX)
0.2003
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
0.2003
0.00 (0.00%)
After-Hours: 19:18
Viracta Therapeutics Total Assets (Quarterly): 31.32M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 31.32M |
| March 31, 2024 | 41.33M |
| December 31, 2023 | 56.69M |
| September 30, 2023 | 66.44M |
| June 30, 2023 | 76.86M |
| March 31, 2023 | 85.78M |
| December 31, 2022 | 95.99M |
| September 30, 2022 | 82.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 89.16M |
| March 31, 2022 | 98.39M |
| December 31, 2021 | 108.55M |
| September 30, 2021 | 116.54M |
| June 30, 2021 | 128.68M |
| March 31, 2021 | 136.21M |
| December 31, 2020 | 48.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.32M
Minimum
Jun 2024
136.21M
Maximum
Mar 2021
84.16M
Average
85.78M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 160.04M |
| GlycoMimetics Inc | 24.42M |
| FibroGen Inc | 293.20M |
| Cidara Therapeutics Inc | 173.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.65M |
| Shareholders Equity (Quarterly) | 2.671M |